NuPathe, Inc. (PATH) Reports In-Line Q3 Loss of 51c/Share
Tweet
Share
E-mailGet Alerts PATH Hot Sheet
Join SI Premium – FREE
NuPathe, Inc. (NASDAQ: PATH) reported Q3 EPS of ($0.51), in-line with the analyst estimate of ($0.51).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UiPath Inc. (PATH) PT Raised to $15 at RBC Capital
- Movano (MOVE) Misses Q2 EPS by 195c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
